Drug information for PEGANONE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 250MG Prescription  (Reference Drug) ETHOTOIN ethotoin LUNDBECK INC 10841
2011-06-02 Letter
2010-06-30 Other
2010-06-24 Medication Guide
2010-06-14 Label
2010-06-14 Letter
2009-04-29 Letter
2009-04-28 Label
2007-02-21 Label
2007-02-12 Letter
2003-10-01 Letter
2003-10-01 Letter
TABLET; ORAL 500MG Discontinued   ETHOTOIN ethotoin LUNDBECK INC   "

Drug Adverse Effects information for PEGANONE

Role code Indications Reaction # Reports
PS EPILEPSY DIPLOPIA 1
PS EPILEPSY OSTEOPOROSIS 1
C OSTEOPOROSIS BACK DISORDER 3
C OSTEOPOROSIS BACK PAIN 3
C OSTEOPOROSIS BALANCE DISORDER 3
C OSTEOPOROSIS DEVICE BREAKAGE 3
C OSTEOPOROSIS DISTURBANCE IN ATTENTION 3
C OSTEOPOROSIS FALL 3
C OSTEOPOROSIS HEAD INJURY 3
C OSTEOPOROSIS HOSPITALISATION 1
C OSTEOPOROSIS INJECTION SITE PAIN 3
C OSTEOPOROSIS JOINT DISLOCATION 3
C OSTEOPOROSIS LIMB DISCOMFORT 3
C OSTEOPOROSIS LIMB INJURY 3
C OSTEOPOROSIS LUMBAR HERNIA 3
C OSTEOPOROSIS MOBILITY DECREASED 3
C OSTEOPOROSIS MUSCLE SPASMS 3
C OSTEOPOROSIS NECK PAIN 3
C OSTEOPOROSIS NERVE COMPRESSION 3
C OSTEOPOROSIS NERVOUS SYSTEM DISORDER 3
C OSTEOPOROSIS PAIN IN EXTREMITY 3
C OSTEOPOROSIS SENSORY LOSS 3
C OSTEOPOROSIS SPINAL COLUMN INJURY 3
C OSTEOPOROSIS WEIGHT INCREASED 3
Ads by Google